A team of scientists at the Icahn School of Medicine at Mount Sinai has achieved a breakthrough in neurological treatment by developing a novel lipid nanoparticle system capable of delivering messenger RNA (mRNA) directly to the brain through intravenous injection. This advancement overcomes the longstanding challenge posed by the blood-brain barrier, opening up new possibilities for treating a wide range of neurological and psychiatric disorders.
Scientists at the Icahn School of Medicine at Mount Sinai have made a groundbreaking discovery in the field of neurological treatment. They have developed a novel lipid nanoparticle system capable of delivering messenger RNA (mRNA) directly to the brain via an intravenous injection. This achievement is particularly significant because the blood-brain barrier, a protective shield surrounding the brain, has long posed a formidable challenge to delivering therapeutic substances like mRNA.
\The findings, which were conducted on mouse models and isolated human brain tissue, were published in the February 17 online issue of Nature Materials. This research showcases the immense potential of this technology to revolutionize the treatment of a wide range of neurological and psychiatric disorders, including Alzheimer's disease, amyotrophic lateral sclerosis, brain cancer, and drug addiction. \The blood-brain barrier acts as a gatekeeper, preventing many substances, including potentially beneficial therapies, from reaching the brain. While previous research from Mount Sinai had explored transporting large biomolecules like proteins and oligonucleotides into the central nervous system, this new study takes a different approach: utilizing specially designed lipid nanoparticles to transport mRNA across the barrier. The ability to deliver mRNA to the brain could empower scientists to instruct brain cells to produce therapeutic proteins. These proteins could play a vital role in treating or preventing disease by replacing missing proteins, reducing harmful ones, or activating the body's natural defenses. \The research team meticulously designed and tested a library of lipids to optimize their ability to cross the blood-brain barrier. Through a series of structural and functional analyses, they identified a lead formulation, termed MK16 BLNP, which demonstrated significantly higher mRNA delivery efficiency compared to existing lipid nanoparticles approved by the Food and Drug Administration (FDA). This system leverages natural transport mechanisms within the blood-brain barrier, including caveolae- and γ-secretase-mediated transcytosis, to facilitate the movement of nanoparticles across the barrier. \In studies utilizing mouse models of disease, the BLNP platform successfully delivered therapeutic mRNAs to the brain, providing compelling evidence of its potential for clinical application. The researchers emphasize that while this discovery is a significant step forward, further studies are essential to evaluate the long-term safety and efficacy of this technology, including toxicology studies in accordance with FDA guidelines. Future research will focus on refining the technology for clinical translation, paving the way for a new era of brain disease treatment
BLOOD-BRAIN BARRIER LIPID NANOPARTICLES Mrna DELIVERY NEUROLOGICAL DISORDERS GENE THERAPY
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers Develop Human Marrow-on-a-Chip to Study Immune System and Treat DiseasesScientists at the University of Pennsylvania, Perelman School of Medicine, and Children's Hospital of Philadelphia have created a groundbreaking 'bone marrow-on-a-chip' that mimics the natural environment of human bone marrow. This innovative platform allows researchers to study the complexities of blood cell production, disease effects, and potential treatments in a controlled and human-relevant setting.
Read more »
Topeak UTF Multi-Mount Pro Review: A Versatile and Secure Out-Front Bike MountThis in-depth review examines the Topeak UTF Multi-Mount Pro, a versatile and adjustable out-front mount designed for cyclists. It explores its features, performance, and value proposition compared to other options in the market.
Read more »
Osaka University Researchers Develop New Technique to Understand Treg Function in Immune SystemA team at Osaka University has developed a novel method called scSPOT that allows scientists to study the complex interactions between regulatory T cells (Tregs) and other immune cells. This breakthrough could lead to the development of new treatments for cancer and other diseases.
Read more »
Marco Bezzecchi: "Everything was new, big responsibility" to develop a bike“I’ve never had the possibility to develop a bike…”
Read more »
Manchester United's Injury Woes Mount Ahead of Tottenham ClashManchester United manager Ruben Amorim faces a depleted squad for Sunday's Premier League match against Tottenham Hotspur due to a spate of injuries and illnesses. Leny Yoro and Christian Eriksen are the latest absentees through illness, joining four other players sidelined this week with injuries. The Portuguese boss is left with a bench featuring eight players yet to make their debuts for the club.
Read more »
Arne Slot ‘will develop Jamie Bynoe-Gittens into a superstar at Liverpool’ The inside track on the football stories that matter
Read more »